Research areas
Pharmacometric modelling for individualisation of anticancer drug therapy
Within this research area, we aim to develop and apply pharmacometric models to improve the safety and efficacy of anticancer drug therapy.
Medication safety in cancer patients
To improve medication safety in cancer patients, our research group develops interprofessional care models based on a structured medication management.
Development of risk models to predict adverse drug reactions
The goal of our work in this research area is to develop risk models to predict drug-related problems and adverse drug events in various patient care settings.
Development of pharmaceutical services to improve medication safety
Ongoing research projects on this topic focus on the development and evaluation of novel patient-centered pharmaceutical services with the goal of identifying and preventing drug-related problems.
Model-informed Drug Development and Precision Dosing in Neonates and Infants (MONI)
In this research area, we aim to identify the requirements for accurate estimation of individual pharmacokinetic parameters to guide tailored dosing in neonates and infants.